Plexus Corp. (NASDAQ:PLXS) Stock Has Consensus Price Target of $276.86 According to Brokerages

Plexus Corp. (NASDAQ:PLXS – Get Free Report) has earned a consensus rating of “Buy” from the eight brokerages that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, six have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $276.86.

Several research analysts recently issued reports on the stock. KeyCorp upgraded shares of Plexus from a “sector weight” rating to an “overweight” rating and set a $300.00 price target on the stock in a research report on Monday, September 21st. Needham & Company LLC restated a “buy” rating and issued a $310.00 price objective on shares of Plexus in a research report on Friday, August 14th. Stifel Nicolaus boosted their target price on shares of Plexus from $280.00 to $330.00 and gave the stock a “buy” rating in a research note on Monday, June 22nd. Sidoti upgraded shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 target price on the stock in a research report on Friday, July 31st. Finally, Weiss Ratings cut shares of Plexus from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, September 9th.

Read Our Latest Research Report on PLXS

Insiders Place Their Bets

In other news, Director Michael V. Schrock sold 4,000 shares of Plexus stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $275.00, for a total transaction of $1,100,000.00. Following the transaction, the director directly owned 40,329 shares of the company’s stock, valued at $11,090,475. This trade represents a 9.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Karen Rapp sold 500 shares of the stock in a transaction on Monday, August 31st. The stock was sold at an average price of $240.87, for a total transaction of $120,435.00. Following the sale, the director directly owned 7,535 shares of the company’s stock, valued at $1,814,955.45. This represents a 6.22% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 7,500 shares of company stock valued at $1,960,520. 1.78% of the stock is currently owned by corporate insiders.

Institutional Trading of Plexus

A number of hedge funds and other institutional investors have recently made changes to their positions in PLXS. Allworth Financial LP increased its position in shares of Plexus by 20.8% in the fourth quarter. Allworth Financial LP now owns 302 shares of the technology company’s stock valued at $44,000 after acquiring an additional 52 shares during the last quarter. Trust Point Inc. boosted its position in Plexus by 5.5% during the second quarter. Trust Point Inc. now owns 1,308 shares of the technology company’s stock valued at $393,000 after purchasing an additional 68 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its position in Plexus by 6.0% during the first quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 1,858 shares of the technology company’s stock valued at $376,000 after purchasing an additional 105 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in Plexus in the second quarter valued at approximately $32,000. Finally, Kilter Group LLC bought a new position in Plexus in the second quarter valued at approximately $40,000. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Plexus Stock Performance

NASDAQ:PLXS opened at $263.09 on Wednesday. The stock has a market capitalization of $7.04 billion, a P/E ratio of 38.80 and a beta of 0.89. The company has a current ratio of 1.49, a quick ratio of 0.72 and a debt-to-equity ratio of 0.06. Plexus has a 1 year low of $132.03 and a 1 year high of $307.06. The firm has a 50 day moving average of $253.01 and a 200-day moving average of $251.37.

Plexus (NASDAQ:PLXS – Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.13 by $0.19. The firm had revenue of $1.30 billion during the quarter, compared to the consensus estimate of $1.23 billion. Plexus had a return on equity of 12.46% and a net margin of 4.03%.The business’s revenue for the quarter was up 28.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. As a group, sell-side analysts anticipate that Plexus will post 7.13 EPS for the current fiscal year.

Plexus News Roundup

Here are the key news stories impacting Plexus this week:

  • Positive Sentiment: KeyCorp reiterated an Overweight rating and a $300 price target, implying additional upside from recent levels. The firm forecasts Plexus will earn $7.18 per share in fiscal 2026 and $8.74 per share in fiscal 2027, with quarterly EPS estimates rising from $2.01 in Q1 2027 to $2.35 in Q4 2027. Those projections point to continued earnings growth.
  • Positive Sentiment: The latest quarterly results provide support for the bullish outlook: Plexus previously exceeded EPS and revenue expectations, reporting $2.32 in EPS on $1.30 billion of revenue, with revenue up 28.2% year over year.
  • Neutral Sentiment: A report stated that Plexus was the subject of a significant increase in short interest, but also listed total short interest at zero shares and a days-to-cover ratio of 0.0. The data appears internally inconsistent, so it offers little reliable insight into current trading sentiment.
  • Negative Sentiment: A Seeking Alpha analysis argues that Plexus’s growth must be accompanied by stronger cash generation. The article’s focus on cash conversion signals a potential concern for investors even as revenue and earnings expand, particularly because the stock trades at a relatively elevated valuation of about 39 times earnings. Plexus: Growth Has Arrived, But The Cash Must Follow

About Plexus

(Get Free Report)

Plexus Corp. is a global electronics manufacturing services company that designs, manufactures and services products for original equipment manufacturers. The company supports customers across the product life cycle, from product development and engineering to supply chain management, assembly, testing, fulfillment and aftermarket services.

Plexus provides solutions for industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.

Featured Stories

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.